The Relationship Between Clinical Outcomes and Calculated Thrombus Burden Before and After Initial Flow in Patients
Oğuzhan Birdal1, Selim Topçu1, İbrahim Halil Tanboğa1
1Department of Cardiology, Atatürk University Faculty of Medicine, Erzurum, Turkey.
Insights
Thrombus burden in ST-segment elevation myocardial infarction (STEMI) impacts outcomes. Higher basal thrombus burden predicts no-reflow, while final thrombus burden is linked to 1-year mortality after primary percutaneous coronary intervention.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Coronary Syndromes
Background:
- Primary percutaneous coronary intervention (PCI) is standard for ST-elevation myocardial infarction (STEMI).
- High thrombus burden can compromise procedural success and patient outcomes.
- Assessing thrombus burden may improve risk stratification.
Purpose of the Study:
- To investigate the association between thrombus burden, assessed before and after initial flow, and clinical outcomes in STEMI patients undergoing primary PCI.
- To determine if thrombus burden predicts no-reflow and 1-year all-cause mortality.
Main Methods:
- Retrospective analysis of 1376 STEMI patients treated with primary PCI between May 2012 and November 2015.
- Thrombus burden quantified using Thrombolysis in Myocardial Infarction (TIMI) thrombus grades (baseline and final).
- Primary endpoints: post-PCI no-reflow and 1-year all-cause mortality.
Main Results:
- No-reflow occurred in 12.3% of patients.
- Higher basal thrombus burden was significantly associated with no-reflow (P < .001).
- Higher final thrombus burden was significantly associated with 1-year all-cause mortality (P = .047).
Conclusions:
- Basal thrombus burden is a predictor of no-reflow post-primary PCI.
- Final thrombus burden is associated with 1-year all-cause mortality in STEMI patients.
- Quantifying thrombus burden before and after initial flow aids in predicting clinical outcomes.
Objective:
Primary percutaneous coronary intervention is the standard treatment for ST-segment eleva- tion myocardial infarction. Although myocardial and epicardial perfusion is usually achieved with primary percutaneous coronary intervention, infarct-related arterial thrombus burden negatively affects the proce- dural success and clinical outcomes of primary percutaneous coronary intervention. Therefore, we aimed to investigate the association between thrombus burden (calculated before and after initial flow) and clinical consequences in patients with ST-segment elevation myocardial infarction.
Materials And Methods:
This study retrospectively enrolled 1376 patients who had ST-segment elevation myo- cardial infarction between May 2012 and November 2015. Patients who had only undergone balloon angio- plasty and emergency coronary artery bypass grafting were not included in the study. Data regarding the initial clinical and demographic features of the patients were obtained from their hospital records. Thrombus burden was calculated using baseline and final (after wire inflation or small balloon dilatation) thrombolysis in myocardial infarction thrombus grades. The endpoints of the study were defined as no-reflow development after primary percutaneous coronary intervention and 1-year all-cause mortality. Statistical significance was defined as P < .05.
Results:
No-reflow was detected in 169 patients (12.3%). The calculated basal thrombus burden was signifi- cantly associated with post-procedural no-reflow (P < .001). No-reflow was also associated with advanced age (P < .001), longer pain-to-door time (P < .001), and increased blood glucose levels (P = .032). The calcu- lated final thrombus burden was related to 1-year all-cause mortality (P = .047). One-year all-cause mortality was also associated with advanced age (P < .001), high Killip scores (P=.003), increased white blood cell counts (P = .001), and low estimated glomerular filtration rates (P < .001).
Conclusion:
Basal thrombus burden was associated with no-reflow, and final thrombus burden was associ- ated with 1-year all-cause mortality. The calculation of thrombus burden before and after initial flow may help to predict clinical outcomes.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome I: Introduction


